Earnings results for Microbot Medical Stock Forecast, Price & News (NASDAQ:MBOT)
Microbot Medical Inc. is estimated to report earnings on 09/02/2020. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.36.
Analyst Opinion on Microbot Medical Stock Forecast, Price & News (NASDAQ:MBOT)
1 Wall Street analysts have issued ratings and price targets for Microbot Medical in the last 12 months. Their average twelve-month price target is $20.00, predicting that the stock has a possible upside of 205.81%. The high price target for MBOT is $20.00 and the low price target for MBOT is $20.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of “Buy.”
Microbot Medical has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $20.00, Microbot Medical has a forecasted upside of 205.8% from its current price of $6.54. Microbot Medical has only been the subject of 1 research reports in the past 90 days.
Dividend Strength: Microbot Medical Stock Forecast, Price & News (NASDAQ:MBOT)
Microbot Medical does not currently pay a dividend. Microbot Medical does not have a long track record of dividend growth.
Insiders buying/selling: Microbot Medical Stock Forecast, Price & News (NASDAQ:MBOT)
In the past three months, Microbot Medical insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $154,063.00 in company stock. Only 8.69% of the stock of Microbot Medical is held by insiders. Only 8.21% of the stock of Microbot Medical is held by institutions.
Earnings and Valuation of Microbot Medical Stock Forecast, Price & News (NASDAQ:MBOT
Earnings for Microbot Medical are expected to decrease in the coming year, from ($1.14) to ($1.25) per share. Microbot Medical has a P/B Ratio of 1.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.
More latest stories: here